Improving Decision-Making in Drug Development Using In Vitro Toxicology Screening

By Suter Willi  

International Journal of Pharmaceutical Medicine, Vol. 21, Iss. 5, 2007-01 ,pp. : 347-355

Adis International

Access to resources Recommend Favorite

Development of a decision-making framework in Canada

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 636, 2011-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Biomarkers for Early Detection of Non-Alcoholic Steatohepatitis: Implications for Drug Development and Clinical Trials

By  

Current Drug Targets, Vol. 14, Iss. 11, 2013-10 ,pp. : 1357-1366

Bentham Science Publishers

Access to resources Recommend Favorite

Biomarker Analysis as a Decision-Making Tool in Drug Discovery and Development: Implications for Peroxisome Proliferator-Activator Receptors

By Stoch S. Aubrey   Wagner John A.  

International Journal of Pharmaceutical Medicine, Vol. 21, Iss. 4, 2007-01 ,pp. : 271-277

Adis International

Access to resources Recommend Favorite

How Modeling and Simulation Have Enhanced Decision Making in New Drug Development

By Miller Raymond   Ewy Wayne   Corrigan Brian   Ouellet Daniele   Hermann David   Kowalski Kenneth   Lockwood Peter   Koup Jeffrey   Donevan Sean   El-Kattan Ayman   Li Cheryl   Werth John   Feltner Douglas   Lalonde Richard  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 32, Iss. 2, 2005-04 ,pp. : 185-197

Springer Publishing Company

Access to resources Recommend Favorite